.

follow-on-google-news

Multibagger stock engaged in the business of manufacturing pesticides, fertilizers and many more jumped 3 percent in the day’s trade after it received an export order for the supply of insecticide that is used to control mosquitos and diseases related to it. 

At 11:30 a.m the shares of 3B Blackbio DX Limited formerly were trading at Rs. 834, up 2.53 percent from its previous day’s close price of Rs. 813.40 and its market capitalization is Rs. 626 Crores. 

3B Blackbio DX Limited’s agro division has received an export order worth Rs. 1.59 Crore for the supply of TEMEPHOS 50% EC. It is mainly used as a larvicide to control mosquitoes in domestic water containers and those used for storing drinking water. With growing global concern for mosquito-borne diseases, this product will have a good future to combat the problem. 

3B Blackbio DX Limited formerly known as Kilpest India Limited is engaged in the business of manufacturing pesticide products, micro fertilizers, biofertilizers, biopesticides, public health products and many more. 

Its revenue from operations declined by 23.32 percent from Rs. 80.65 Crores in FY22 to Rs. 61.84 Crores in FY23, accompanied by profits of Rs. 32.2 Crores to Rs. 25.94 Crores. 

It has reported a return on equity (ROE) of 16 percent and a return on capital employed (ROCE) of 21.6 percent, it is making good returns on its equity and capital employed. 

According to the latest shareholding data available for the quarter ended December 2023, the company’s Promoters hold 38.43 percent stake, the Foreign Institutional Investors (FII) hold 3.38 percent and the Domestic Institutional Investors hold 1.19 percent. 

Written by: Bharath K.S

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

×